Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are investigating the safety, feasibility, and preliminary effectiveness of expanded allogeneic mesenchymal stem cells derived from adipose tissue HC106 for treating urinary incontinence in women over 50 years old. This phase I controlled trial aims to compare the effects of HC106 cells with a placebo in women diagnosed with stress or mixed urinary incontinence who have not responded to or declined rehabilitative or surgical treatments. Participants are divided into two groups one receives a single dose of 40 million HC016 cells injected near the external urinary sphincter, and the other receives a placebo consisting of the saline solution used to condition the cells. The injection procedure involves anesthesia, identifying the target area via cystoscopy, and carefully injecting the cell suspension at two specific points. The placebo group undergoes the same procedure using saline solution. The study uses a randomized, double-blind design. Throughout the study, participants are monitored for complications within 7 days after treatment and assessed for urinary leakage, flowmetry, and quality of life at 3 and 6 months using standardized tests and questionnaires. Researchers track safety, treatment effects, and quality of life changes over time. The total duration of participation includes initial treatment and follow-up visits up to six months.